Troxipide
-
Troxipide
structure -
-
CAS No:
30751-05-4
-
Formula:
C15H22N2O4
-
Chemical Name:
Troxipide
-
Synonyms:
Benzamide,3,4,5-trimethoxy-N-3-piperidinyl-;Benzamide,3,4,5-trimethoxy-N-3-piperidyl-;3,4,5-Trimethoxy-N-3-piperidinylbenzamide;3-(3,4,5-Trimethoxybenzamido)piperidine;KU 54;Troxipide;Aplace;(N-Piperidin-3-yl)-3,4,5-trimethoxybenzamide;99777-81-8
- Categories:
-
CAS No:
Description
Troxipide is a novel gastro protective agent with antiulcer, anti-inflammatory and mucus secreting properties.
Troxipide is a member of benzamides.
Troxipide Basic Attributes
294.34600
294.35
DTXSID2023725
A - Alimentary tract and metabolism
2933399090
Characteristics
68.82000
1.91390
white powder
1.18g/cm3
179-185 °C
407.5ºC at 760 mmHg
200.3ºC
1.546
Safety Information
P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, P362
H315
|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, and P362|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Troxipide Use and Manufacturing
Troxipide is a drug used in the treatment of gastroesophageal reflux disease. Troxipide is a novel systemic non-antisecretory gastric cytoprotective agent with anti-ulcer, anti-inflammatory and mucus secreting properties irrespective of pH of stomach or duodenum. Troxipide is currently marketed in Japan (Aplace), China (Shuqi), South Korea (Defensa), and India (Troxip). It is used for the management of gastric ulcers, and amelioration of gastric mucosal lesions in acute gastritis and acute exacerbation of chronic gastritis.
Computed Properties
Molecular Weight:294.35
XLogP3:1.2
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:5
Exact Mass:294.15795719
Monoisotopic Mass:294.15795719
Topological Polar Surface Area:68.8
Heavy Atom Count:21
Complexity:326
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Drug Function and Efficacy
It is a new type of defense factor-enhanced gastritis and gastric ulcer therapeutic agent. It has an inhibitory effect on various experimental ulcers, a therapeutic and preventive effect on experimental gastritis, and a preventive effect on acute gastric mucosal lesions. It can enhance the blood flow of the gastric mucosa and promote tissue repair. Unlike H2-receptor antagonists, it has no effect on gastric acid secretion, but enhances the defense factors of the gastric mucosa and promotes the repair of gastric ulcer sites.
Registered Holders
-
PKU HealthCare Corp., Ltd.
Active
China
-
Hanrui Pharmaceutical (Jingmen) Co., Ltd.
Inactive
China
Recommended Suppliers of Troxipide
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives
Learn More Other Chemicals
-
Sofalcone
64506-49-6
-
Dolasetron mesylate
115956-13-3
-
Lorcaserin hydrochloride
846589-98-8
-
(-)-Omeprazole Formula
119141-88-7
-
Alvimopan Formula
156053-89-3
-
Alibendol Formula
26750-81-2
-
alpha-d-Glucopyranosiduronic acid, (3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-d-glucopyranuronosyl-, potassium salt Structure
68039-19-0
-
(-)-Alkannin Structure
517-88-4
-
What is Orazamide
2574-78-9
-
What is D-GLUCURONO-3,6-LACTONE
32499-92-6